Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trabectedin and Irinotecan in Pediatric Refractory Sarcomas

NCT02509234 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT02509234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02509234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trabectedin and Irinotecan in Pediatric Refractory Sarcomas
Lead sponsor
Technical University of Munich
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2014
Completion date
July 31, 2017
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent childhood soft tissue sarcoma, recurrent ewing sarcoma, recurrent rhabdomyosarcoma